Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 3Not yet recruiting 2Terminated 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 1401Neoplasms 1128Prostatic Neoplasms 745Lung Neoplasms 621Colorectal Neoplasms 599Carcinoma, Non-Small-Cell Lung 570Carcinoma, Hepatocellular 414Pancreatic Neoplasms 402Leukemia, Myeloid, Acute 398Stomach Neoplasms 356Multiple Myeloma 326Brain Neoplasms 311Ovarian Neoplasms 310Head and Neck Neoplasms 290Neoplasm Metastasis 275Precursor Cell Lymphoblastic Leukemia-Lymphoma 260Rectal Neoplasms 254Uterine Cervical Neoplasms 248Recurrence 248Melanoma 243Esophageal Neoplasms 237Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 231Lymphoma 214Sarcoma 209Urinary Bladder Neoplasms 192Colonic Neoplasms 192Glioma 191Triple Negative Breast Neoplasms 188Hematologic Neoplasms 182

Interventions

Neoadjuvant Therapy 1FAPI-46 1Endosonography 1Blood Specimen Collection 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × Pancreatic Ductal Adenocarcinoma (PDAC) × Clear all
NCT06659705 2026-04-15

INDIGO-FAPI

Institut Curie

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT04990609 2025-05-21

EUS-RFA PANCARDINAL-1 Trial

The University of Texas Health Science Center, Houston

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT04575363 2023-11-09

PaCaBioMarkeR

CHU de Reims

Phase NA Recruiting
90 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡